Biden’s Alzheimer’s Lapse - Another Devil's Advocate

0 Comments
263
September 29, 2022
SOURCE
WSJ (may require subscription)
Read Article Here
His Administration increased Part B premiums by 14.5% this year and blamed the increase on expected high demand for Biogen’s Alzheimer’s drug Aduhelm, which the Food and Drug Administration approved last summer.
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Tags Cloud

Another Devil’s advocate © 2021. All rights reserved.

Web Design by Tags & Elements